Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Abrdn Healthcare Opportunities Fund Shares Of Beneficial Int | THQ | Nov 25, 2024 | 20.30 | +2.37 |
Abrdn Life Sciences Investors Shares Of Beneficial Interest | HQL | Nov 25, 2024 | 13.97 | +1.31 |
Abrdn National Municipal Income Fund | VFL | Nov 25, 2024 | 10.73 | +1.08 |
Abrdn Total Dynamic Dividend Fund | AOD | Nov 25, 2024 | 8.75 | +0.46 |
Abrdn World Healthcare Fund Shares Of Beneficial Interest | THW | Nov 25, 2024 | 11.93 | +0.93 |
Absci | ABSI | Nov 25, 2024 | 2.83 | +10.55 |
ABVC Biopharma | ABVC | Nov 25, 2024 | 0.52 | -4.88 |
Ac Immune SA | ACIU | Nov 25, 2024 | 3.41 | +0.89 |
Acacia Research | ACTG | Nov 25, 2024 | 4.58 | +0.44 |
Academy Sports and Outdoors | ASO | Nov 25, 2024 | 49.44 | +6.00 |
Acadia Healthcare | ACHC | Nov 25, 2024 | 39.99 | +4.60 |
Acadia Pharmaceuticals | ACAD | Nov 25, 2024 | 16.54 | +1.04 |
Acadia Realty Trust | AKR | Nov 25, 2024 | 25.59 | +1.47 |
Acasti Pharma, Inc. | ACST | Nov 25, 2024 | 3.37 | 0.00 |
Accel Entertainment | ACEL | Nov 25, 2024 | 11.71 | +0.60 |
Accelerate Diagnostics | AXDX | Nov 25, 2024 | 1.64 | 0.00 |
Accenture A | ACN | Nov 25, 2024 | 361.29 | +0.73 |
Acco Brands | ACCO | Nov 25, 2024 | 5.96 | +2.41 |
Accolade | ACCD | Nov 25, 2024 | 3.80 | +2.70 |
Accuray | ARAY | Nov 25, 2024 | 2.03 | +5.18 |
Acelyrin | SLRN | Nov 25, 2024 | 4.73 | +0.64 |
Achieve Life Sciences | ACHV | Nov 25, 2024 | 4.51 | +5.13 |
Achilles Therapeutics ADR | ACHL | Nov 25, 2024 | 1.07 | +0.94 |
ACI Worldwide | ACIW | Nov 25, 2024 | 58.31 | -0.56 |
Aclarion | ACON | Nov 25, 2024 | 0.18 | +0.40 |
Aclaris Therapeutics | ACRS | Nov 25, 2024 | 3.99 | +5.00 |
ACM Research A | ACMR | Nov 25, 2024 | 18.44 | -1.86 |
Acme United | ACU | Nov 25, 2024 | 44.75 | +4.17 |
ACNB | ACNB | Nov 25, 2024 | 48.37 | +0.85 |
ACRES Commercial Realty | ACR | Nov 25, 2024 | 17.30 | +3.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.